Results 21 to 30 of about 1,772,484 (313)
Journal of the Chinese Medical Association, 2015 Nurses are the largest group of health care providers and, therefore, are often at the forefront of epidemics: responding, treating, educating, and coordinating care as needed. But what happens when nurses are afraid of contracting an illness and decide to leave the workplace?
Nadia Laverne, Etienne +2 more
+8 more sources
Current state of Ebola virus vaccines: A snapshot
PLoS Pathogens, 2021 Why are Ebola virus vaccines needed? Four species of the genus Ebolavirus cause severe and often lethal disease in humans: Sudan ebolavirus (SUDV), Bundibugyo ebolavirus (BDBV), Taï Forest ebolavirus (TAFV), and Zaire ebolavirus (EBOV) [1]. Historically,
Courtney Woolsey, T. Geisbert
semanticscholar +1 more source
Frontiers in Public Health, 2023 Ebola is a highly pathogenic virus, which in humans reaches a mortality rate above 50%. Due to a lack of laboratories in territories where Ebola viruses are endemic and the limited number of surveillance programmes, tests for the confirmation of suspected cases of Ebola are often performed in Reference Laboratories.
Bettini, Aurora +2 more
openaire +3 more sources
Infectious Diseases of Poverty, 2015 Ebola virus disease (EVD) has mostly affected economically deprived countries as limited resources adversely affect a country's infrastructure and administration. Probing into the factors that led to the widespread outbreak, setting forth plans to counter EVD cases in developing countries, and devising definitive measures to limit the spread of the ...
Haider Ghazanfar +3 more
openaire +3 more sources
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
New England Journal of Medicine, 2019 BACKGROUND Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial.
S. Mulangu +50 more
semanticscholar +1 more source
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses
Science, 2020 The CIITAdel keeps viruses at bay A better understanding of cellular mechanisms involved in viral resistance is needed for the next generation of antiviral therapies. Bruchez et al.
Anna M. Bruchez +14 more
semanticscholar +1 more source
The laboratory health system and its response to the Ebola virus disease outbreak in Liberia
African Journal of Laboratory Medicine, 2016 The laboratory system in Liberia has generally been fragmented and uncoordinatedAccordingly, the country’s Ministry of Health established the National Reference Laboratoryto strengthen and sustain laboratory services. However, diagnostic testing services
Stephen B. Kennedy +7 more
doaj +1 more source
Viruses, 2022 During outbreaks of virus diseases, many variants may appear, some of which may be of concern. Stability in an aerosol of several Ebola virus and Marburg virus variants was investigated.
Sophie J. Smither +2 more
doaj +1 more source
Rapid bedside inactivation of Ebola virus for safe nucleic acid tests [PDF]
, 2016 Rapid bedside inactivation of Ebola virus would be a solution for the safety of medical and technical staff, risk containment, sample transport and high-throughput or rapid diagnostic testing during an outbreak.
Bragstad, Karoline +9 more
core +1 more source
Care and COVID 19: Lessons for liberals and neoliberals
Child &Family Social Work, EarlyView., 2023 Abstract Within the liberal political traditions, care is regarded as a private matter, a problem of ethics rather than justice. Social justice is framed as an issue of economics (re/distribution), culture (recognition) and/or politics (representation).
Kathleen Lynch
wiley +1 more source